Doyle Mittie

Avalo Therapeutics, Inc. ยท Chief Medical Officer

Doyle Mittie is listed in public filings as officer: Chief Medical Officer. This Doyle Mittie insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Avalo Therapeutics, Inc. (AVTX), and Cullinan Therapeutics, Inc. (CGEM). Investors use Doyle Mittie's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Avalo Therapeutics, Inc.AVTX$754k47.1k sharesSellMay 28, 2026$10.9K679 shares$16.00--
Avalo Therapeutics, Inc.AVTX$384k47.8k sharesGrant / ExerciseMay 28, 2026$5.5K679 shares$8.04--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Avalo Therapeutics, Inc.AVTX--47.1k sharesGrant / ExerciseMay 21, 2026Disclosure amount unavailable43.5k shares----
Avalo Therapeutics, Inc.AVTX$68k3.6k sharesSellMay 15, 2026$56.3K3k shares$18.76--
Avalo Therapeutics, Inc.AVTX$84k6.6k sharesGrant / ExerciseMay 15, 2026$38.0K3k shares$12.65--
Avalo Therapeutics, Inc.AVTX$1.0M81.5k sharesGrant / ExerciseMay 6, 2026$985.5K77.9k shares$12.65--
Avalo Therapeutics, Inc.AVTX$693k32.7k sharesSellMay 6, 2026$952.7K44.9k shares$21.20--
Avalo Therapeutics, Inc.AVTX$1.5M82.6k sharesSellMay 6, 2026$496.4K27.5k shares$18.03--
Avalo Therapeutics, Inc.AVTX$307k13.7k sharesSellMay 6, 2026$426.1K19k shares$22.41--
Avalo Therapeutics, Inc.AVTX$886k110.2k sharesGrant / ExerciseMay 6, 2026$230.3K28.7k shares$8.04--
Avalo Therapeutics, Inc.AVTX$83k3.6k sharesSellMay 6, 2026$230.1K10.1k shares$22.88--
Avalo Therapeutics, Inc.AVTX$1.5M77.6k sharesSellMay 6, 2026$98.3K5k shares$19.65--
Avalo Therapeutics, Inc.AVTX$58k3.6k sharesSellMay 5, 2026$26.9K1.7k shares$16.00--
Avalo Therapeutics, Inc.AVTX$58k4.6k sharesGrant / ExerciseMay 5, 2026$12.7K1k shares$12.65--
Avalo Therapeutics, Inc.AVTX$43k5.3k sharesGrant / ExerciseMay 5, 2026$5.5K679 shares$8.04--
Avalo Therapeutics, Inc.AVTX$65k3.6k sharesSellApr 6, 2026$71.5K4k shares$18.01--
Avalo Therapeutics, Inc.AVTX$96k7.6k sharesGrant / ExerciseApr 6, 2026$50.2K4k shares$12.65--
Avalo Therapeutics, Inc.AVTX$58k3.6k sharesSellApr 1, 2026$10.9K679 shares$16.00--
Avalo Therapeutics, Inc.AVTX$35k4.3k sharesGrant / ExerciseApr 1, 2026$5.5K679 shares$8.04--
Avalo Therapeutics, Inc.AVTX$58k3.6k sharesSellMar 16, 2026$411.6K25.5k shares$16.15--
Avalo Therapeutics, Inc.AVTX$292k23.1k sharesGrant / ExerciseMar 16, 2026$246.7K19.5k shares$12.65--
Avalo Therapeutics, Inc.AVTX$234k29.1k sharesGrant / ExerciseMar 16, 2026$48.2K6k shares$8.04--
Avalo Therapeutics, Inc.AVTX$1.9M105k sharesGrant / ExerciseFeb 26, 2026$1.9M105k shares$17.64--
Avalo Therapeutics, Inc.AVTX$15k3.6k sharesGrant / ExerciseDec 10, 2025$4.2K1k shares$4.10--
Cullinan Therapeutics, Inc.CGEM$559k79.5k sharesGrant / ExerciseAug 7, 2025$558.6K79.5k shares$7.03--
Avalo Therapeutics, Inc.AVTX$1.2M155k sharesGrant / ExerciseJan 28, 2025$1.2M155k shares$8.04--
Avalo Therapeutics, Inc.AVTX$3.0M234k sharesGrant / ExerciseJul 15, 2024$3.0M234k shares$12.65--